1. Home
  2. NTIC vs ANIX Comparison

NTIC vs ANIX Comparison

Compare NTIC & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$8.10

Market Cap

83.1M

Sector

Industrials

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.84

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTIC
ANIX
Founded
1970
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.1M
88.8M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
NTIC
ANIX
Price
$8.10
$2.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
11.7K
144.7K
Earning Date
04-09-2026
05-27-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
12.82
EPS
0.02
N/A
Revenue
$84,234,474.00
$210,000.00
Revenue This Year
$12.49
N/A
Revenue Next Year
$7.64
N/A
P/E Ratio
$402.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.14
$2.32
52 Week High
$10.03
$5.46

Technical Indicators

Market Signals
Indicator
NTIC
ANIX
Relative Strength Index (RSI) 51.34 61.54
Support Level $7.86 $2.73
Resistance Level $8.25 $3.12
Average True Range (ATR) 0.13 0.18
MACD 0.01 0.04
Stochastic Oscillator 60.00 95.16

Price Performance

Historical Comparison
NTIC
ANIX

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: